New report 2026 AI SDR market benchmark: six platforms, eight workflow stages See the results →

The Report

Verified funding, headquarters, and leadership news from the world's most innovative businesses

186 reports and counting

Updated daily with latest market intelligence
Fundraising
Recursion Pharmaceuticals

Recursion Pharmaceuticals Raises $239M in Series F

Recursion Pharmaceuticals, a Biotech company based in 41 South Rio Grande Street, Salt Lake City, UT 84101, has raised $239M in Series F at a $4B valuation led by Baillie Gifford, ARK Investment Management, Mubadala Capital, Kinnevik, Catalio Capital Management.

Fundraising News Team
Apr 24, 2024
0 min read
Biotech
Recursion Pharmaceuticals

Recursion Pharmaceuticals raises $239M Series F at $4B valuation

Recursion Pharmaceuticals raises $239M in Series F at $4B valuation. AI-powered drug discovery...

Editorial Team
Apr 24, 2024
0 min read•$239M
Pharmaceutical
Vertex Pharmaceuticals

Vertex Pharmaceuticals raises $120B Public at $130B valuation

Vertex Pharmaceuticals raises $120B in Public at $130B valuation. Pharmaceutical company...

Editorial Team
Jan 1, 2024
0 min read•$120B
Pharmaceuticals
Takeda Pharmaceutical

Takeda Pharmaceutical raises $60B Public at $65B valuation

Takeda Pharmaceutical raises $60B in Public at $65B valuation. Pharmaceutical company...

Editorial Team
Jan 1, 2024
0 min read•$60B
Fundraising
Takeda Pharmaceutical

Takeda Pharmaceutical Raises $60B in Public

Takeda Pharmaceutical, a Pharmaceuticals company based in 1-1 Doshomachi 4-chome, Osaka 540-8645, Japan, has raised $60B in Public at a $65B valuation led by Public.

Fundraising News Team
Jan 1, 2024
0 min read
Fundraising
Teva Pharmaceutical

Teva Pharmaceutical Raises $10B in Public

Teva Pharmaceutical, a Pharmaceuticals company based in 124 Dvora HaNevi'a Street, Tel Aviv 6944020, Israel, has raised $10B in Public at a $12B valuation led by Public.

Fundraising News Team
Jan 1, 2024
0 min read
Biotech
Recursion Pharmaceuticals

Recursion Pharmaceuticals Raises $200M

AI-driven drug discovery company using high-throughput biology and machine learning to find new treatments for diseases

David Chen
Oct 23, 2025
0 min read•$200M
Pharmaceutical
Regeneron Pharmaceuticals

Regeneron Pharmaceuticals raises $80B Public at $85B valuation

Regeneron Pharmaceuticals raises $80B in Public at $85B valuation. Biotechnology company...

Editorial Team
Jan 1, 2024
0 min read•$80B
Pharmaceuticals
Teva Pharmaceutical

Teva Pharmaceutical raises $10B Public at $12B valuation

Teva Pharmaceutical raises $10B in Public at $12B valuation. Generic drug manufacturer...

Editorial Team
Jan 1, 2024
0 min read•$10B
Page 1

Showing 9 reports • Page 1 • Category: all

Stay ahead of the market

Get weekly insights delivered to your inbox. No spam, just intelligence.